We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

17 Jun 2026 - 19 Jun 2026
25 Jun 2026 - 27 Jun 2026
05 Oct 2026 - 06 Oct 2026

Reusing Pacemakers from Deceased Donors Is Safe

By HospiMedica International staff writers
Posted on 21 Dec 2011
Permanent pacemakers (PPMs) donated by funeral homes in the United States can be safely and effectively reused, according to a new study. More...


Researchers at Loyola University Medical Center (Maywood, IL, USA) and the University of Texas-Health Science Center (Houston, TX, USA) examined the function of 121 donated PPMs that were sterilized and sent for implantation in needy and indigent patients at a charity hospital in Mumbai (India). From the pool of donated 121 PPMs, 53 were acceptable for reuse and implanted in corresponding patients (mean age 64 years, 53% women). The indications for PPM implantation were complete heart block and sick sinus syndrome.

The researchers found that all the patients were alive and well postoperatively. No significant complications, including infections or device failures, occurred during an average two years of follow-up. All but two patients reported marked improvement in their symptoms. Of the 40 patients (75%), who were followed locally, 4 died due to nonpacemaker-related causes; time to death was a mean 430 days after PPM implantation. While there were only four patients (8%) who were previously employed, all were able to resume their manual labor work. Of the women, 27 patients (96%) reported improvement in symptoms enabling them to resume regular household chores after PPM implantation. The study was published online ahead of print on October 12, 2011, in the American Journal of Cardiology.

“Without pacemakers, these patients would pretty much be forced to remain on confined rest, due to cardiac fatigue,” concluded lead author Gaurav Kulkarni, MD, of Loyola University Medical Center, and colleagues. “Reusing pacemakers could alleviate the burden of symptomatic bradyarrhythmia in impoverished nations around the world.”

The US Food and Drug Administration (FDA) forbids the implantation of used pacemakers within the United States and severely questions its safety, calling it an objectionable practice due to potential sterilization issues, especially in the terminals. There are no federal prohibitions, however, on harvesting used pacemakers for implantation abroad. In India, a new pacemaker costs USD 2,200 to USD 6,600, well beyond the means of many patients.

Related Links:
Loyola University Medical Center
University of Texas-Health Science Center



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Coredio’s CPSE is a a software-as-a-medical-device platform designed for use with consumer smartwatches and standard blood pressure cuffs in clinical and home settings under physician supervision (Photo courtesy of Coredio)

AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure

Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.